Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety Study of Sugammadex in Children 0-2 Years Old

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03728543
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:06.182163+00:00
Published At
2018-11-02T00:00:00+00:00
Record Updated At
2018-11-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Anesthesia", "Pediatric Cancer", "Pediatric Tumor", "Pediatric Hepatoblastoma", "Beta-Thalassemia", "Hepatic Metastases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-11-02"
protocolSection.identificationModule.nctId
"NCT03728543"
protocolSection.identificationModule.officialTitle
"Efficacy and Safety Study of Sugammadex in Children 0-2 Years Old"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Anesthesia (protocolSection.conditionsModule.conditions)
  • Pediatric Cancer (protocolSection.conditionsModule.conditions)
  • Pediatric Tumor (protocolSection.conditionsModule.conditions)
  • Pediatric Hepatoblastoma (protocolSection.conditionsModule.conditions)
  • Beta-Thalassemia (protocolSection.conditionsModule.conditions)
  • Hepatic Metastases (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.